Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination

by Gema Lorenzo, Elena López-Gil, Javier Ortego, Alejandro Brun
Published 2018-02-01

MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses

by Elena López-Gil, Sandra Moreno, Javier Ortego, Belén Borrego, Gema Lorenzo, Alejandro Brun
Published 2020-02-01

A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.

by Elena López-Gil, Gema Lorenzo, Esther Hevia, Belén Borrego, Martin Eiden, Martin Groschup, Sarah C Gilbert, Alejandro Brun
Published 2013-01-01

Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.

by Francisco de la Poza, Eva Calvo-Pinilla, Elena López-Gil, Alejandro Marín-López, Francisco Mateos, Javier Castillo-Olivares, Gema Lorenzo, Javier Ortego
Published 2013-01-01

A novel Schmallenberg virus subunit vaccine candidate protects IFNAR-/- mice against virulent SBV challenge

by Hani Boshra, Gema Lorenzo, Diego Charro, Sandra Moreno, Gabriel Soares Guerra, Isbene Sanchez, Joseba M. Garrido, Marivi Geijo, Alejandro Brun, Nicola G. A. Abrescia
Published 2020-11-01

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus

by Sergio Utrilla-Trigo, Luis Jiménez-Cabello, Ruymán Alonso-Ravelo, Eva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno, Gema Lorenzo, Julio Benavides, Sarah Gilbert, Aitor Nogales, Javier Ortego
Published 2020-06-01